Congress Approves Continuing Resolution to Fund NIH Through February 18

With just hours to spare before its December 3 deadline, Congress averted a government shutdown and passed a continuing resolution (CR) that will fund the government at the previous year’s level through February 18, 2022. We appreciate the Endocrine Society members who participated in our online campaign, which helped avoid a destabilizing shutdown and ensured that Congress understood the consequences of a CR for the endocrine research community.

However, our work is not done.

The CR is a temporary funding measure that allows the government to keep operating, but for most federal programs, including the National Institutes of Health (NIH), funding is held to this year’s level and there are no increases.

With continued advocacy by our members, we believe we can influence Congress to support research funding.

To ensure that the NIH receives the funding increases that the House and Senate have previously agreed to, the Endocrine Society will continue to advocate for Congress to pass a final appropriations bill for the remainder of FY22 with an increase for the NIH before the February 18 deadline.

Be on the lookout at the beginning of 2022 as we launch a new online campaign. With continued advocacy by our members, we believe we can influence Congress to support research funding.

Please see endocrine.org/takeaction for more details.

You may also like

  • Family Matters: Early-Career Scientist Zari McCullers Follows in Her Parents’ Footsteps to the Bench!

    With both her parents working as scientists in the United States Army, it was only natural for Zari McCullers to go into the “family business” when she got the chance. She discusses her career path, how she became focused on the science of addiction, and how making music keeps her grounded when she’s not making…

  • Advocacy in Action – November 2025

    Prescription Drug Pricing Update: Society Continues Advocacy to Lower Price and Out-of-Pocket Costs of Medications    Last month, the Trump Administration and a major retailer took steps to address high prescription drug prices. On September 30, the Trump Administration announced the creation of “TrumpRx,” a consumer website where Americans can buy medications at a discounted price….

Find more in